Activity Stream
@moatrx
• one week ago
Posted a new blog:
GCC SICKLE CELL DISEASE LAUNCH READINESS
GCC SICKLE CELL DISEASE LAUNCH READINESS
GCC sickle cell disease affects 200,000 to 250,000 patients, yet zero novel SFDA-registered therapy exists since crizanlizumab's 2023 withdrawal.
Hydroxyurea is...
